Inspiratory Training in Children After Fontan
Effects of Inspiratory Muscle Training in Children After Fontan Surgery.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
São Paulo, Brazil, 05403-900
- Heart Intitute
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 8 to 12 years;
- Both sexes;
- No history of other heart disease;
- No history of lung and musculoskeletal diseases;
- >1 year post-operative Fontan Surgery;
- Clinically stable;
- Absence of serious arrhythmias;
- Medical clearance to participate in the study; The legal guardian has agreed to participate in the research and the child has consented
Exclusion Criteria:
- Musculoskeletal alterations;
- Patients with neurological sequelae;
- Patients with genetic syndromes associated with cognitive or psychiatric disorders;
- History of perioperative arrhythmias;
- Patients with uncontrolled heart failure;
- Recent angina;
- Severe arrhythmia;
- Hemoptysis;
- Pulmonary hypertension;
- Diaphragmatic plication;
- Moderate to severe asthma.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control Group
The control group consisted of 18 healthy children.
These children underwent cardiopulmonary testing, spirometry, chest ultrasound to assess the diaphragm, 6-minute walk test, respiratory muscle strength and quality of life.
These tests were performed to assess the results of these tests in patients without previous illnesses.
|
|
|
Active Comparator: Fontan Training Group
The Fonta training group consisted of 14 children in the late postoperative period of Fontan surgery.
These children underwent cardiopulmonary testing, spirometry, chest ultrasound to assess the diaphragm, 6-minute walk test, respiratory muscle strength and quality of life.
These tests were performed at the initial stage and after two months of inspiratory muscle training to assess the results of these in postoperative patients and what changes the training could bring.
The training was performed with the Power Breath device, the carda was quantified at 40% of the force exerted at maximum inspiratory pressure by manovacuometry.
The patient was asked to perform 3 sets of 20 repetitions twice over the course of 7 days of the week.
Monitoring was done in person and virtually, and the carda was increased according to the evaluator's perception of the ease of the exercise or if the patient reported it to be easy.
The training lasted 2 months.
|
The Fonta training group consisted of 14 children in the late postoperative period of Fontan surgery.
These children underwent cardiopulmonary testing, spirometry, chest ultrasound to assess the diaphragm, 6-minute walk test, respiratory muscle strength and quality of life.
These tests were performed at the initial stage and after two months of inspiratory muscle training to assess the results of these in postoperative patients and what changes the training could bring.
The training was performed with the Power Breath device, the carda was quantified at 40% of the force exerted at maximum inspiratory pressure by manovacuometry.
The patient was asked to perform 3 sets of 20 repetitions twice over the course of 7 days of the week.
Monitoring was done in person and virtually, and the carda was increased according to the evaluator's perception of the ease of the exercise or if the patient reported it to be easy.
The training lasted 2 months.
|
|
No Intervention: Fonta Control Group
The Fonta Control Group consisted of 13 children in the late postoperative period of Fontan surgery.
These children underwent cardiopulmonary testing, spirometry, chest ultrasound to assess the diaphragm, 6-minute walk test, respiratory muscle strength and quality of life.
These tests were performed at the initial stage and after two months to assess the results of these tests in postoperative patients and whether there was any normal behavior.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of the diaphragm muscle
Time Frame: Baseline to 2 months
|
The mobility and thickness of the diaphragm muscle were assessed using ultrasound in M mode.
Both variables were analyzed during spontaneous, relaxed breathing in terms of both tidal volume and deep breathing at vital capacity.
Muscle mobility was examined along the right and left mid-axillary and parasternal lines with volunteers in both the supine and sitting positions.
Muscle thickness was measured while the patients were in the supine position along the mid-axillary lines during both natural, relaxed and deep breathing.
Measurements were taken in centimeters, with the largest value selected from at least three reproducible measurements.
|
Baseline to 2 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Respiratory muscle strength
Time Frame: Baseline to 2 months
|
Respiratory muscle strength was measured using maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP) with a digital manometer calibrated beforehand.
The MIP was determined by the maximal inspiratory effort from the residual volume (RV), and the MEP was determined by the maximal expiratory effort from the total lung capacity (TLC).
At least three reproducible maneuvers were performed, with the largest value used unless it did not exceed the previous value by more than 20%.
|
Baseline to 2 months
|
|
Lung function test
Time Frame: Baseline to 2 months
|
Pulmonary volume and capacity were evaluated using the spirometer protocol as recommended by the American Thoracic Society guidelines.
For spirometry, at least three acceptable and reproducible maneuvers at each stage were performed using encouragement and positive reinforcement to obtain maximum values.
Forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and the FEV1/FVC ratio were studied, and the predicted values were calculated from previously reported equations
|
Baseline to 2 months
|
|
Six-minute walk test
Time Frame: Baseline to 2 months
|
A submaximal analysis of physical capacity was conducted using the six-minute walk test (6MWT), following the protocol of the American Thoracic Society[16].
The patients were instructed to walk as quickly as possible without running for six minutes, while the distance covered was recorded.
Breaks during the walk were allowed if needed.
The data analyzed included the distance covered in meters, heart rate, respiratory rate, peripheral oxygen saturation, blood pressure, and the Modified Borg Scale for Fatigue.
These measurements were taken at rest one minute before the test, immediately after the test, two minutes after the test if there was an interruption, and five minutes after the test.
|
Baseline to 2 months
|
|
Change in quality of life measurement
Time Frame: Baseline to 2 months
|
The evaluation of quality of life was conducted using the Self-imaginary Questionnaire on Children's Quality of Life (Autoquestionnaire Qualité de Vie Enfant Imagé).
This scale consists of closed questions about the point of view for children aged 4 to 12 years, and their answers are directed toward 'very happy', 'happy', 'unhappy', or 'very unhappy', supported by an image of a child in these emotional states.
The survey included 26 analysis items related to socialization, family relationships, activities, health, isolation, and other functions.
The items were divided into factors such as autonomy, leisure, functions, family, and the legal value of the answers.
The sum of all the questions generates a score with a maximum of 78.
Scores less than 48 are considered to indicate a loss in quality of life.
The questionnaire was validated and translated by Assumpçao et al.
|
Baseline to 2 months
|
|
Improvement exercise tolerance and functional capacity (peak VO2)
Time Frame: Baseline to 2 months
|
Change in functional capacity will be performed by cardiopulmonary exercise test and will be expressed by Peak VO2 and Predicted Peak VO2 (%).
After the training program, an increase in the peak VO2(mL/kg/min) value between 10 to 15% is expected in relation to the baseline value.
|
Baseline to 2 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Marcelo B Jatene, Manager, Heart Institute, University of São Paulo
- Principal Investigator: Joao Bruno PD Silveira, Execution, Heart Institute, University of São Paulo
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 38501214.8.0000.0068
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.